ctrl K

Price Alert

Anixa Biosciences Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

2.94

0.02 (0.68%)

At close: Aug 21, 2025, 11:27 AM

Anixa Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	1.27M	915K	12.36M	29.13M
Short-Term Investments	18.65M	22.93M	17.33M	6.6M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-212K	n/a
Receivables	173K	270K	46K	n/a
Inventory	n/a	n/a	-46K	n/a
Other Current Assets	1.26M	1.24M	n/a	275.56K
Total Current Assets	21.36M	25.36M	30.2M	36M
Property-Plant & Equipment	229K	166K	212K	253.96K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	229K	166K	212K	253.96K
Total Assets	21.59M	25.52M	30.41M	36.26M
Account Payables	525K	206K	265K	136K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	46K	39.4K
Other Current Liabilities	1.95M	n/a	536K	564.18K
Total Current Liabilities	2.5M	2.03M	2.04M	1.27M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	82.00
Total Long-Term Liabilities	203K	123K	175K	220.08K
Total Liabilities	2.7M	2.15M	2.21M	1.49M
Total Debt	232K	175K	221K	259.48K
Common Stock	322K	311K	309K	300.51K
Retained Earnings	-240.75M	-228.2M	-218.38M	-204.79M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	20M	24.34M	29.05M	35.44M
Total Investments	18.65M	22.93M	17.33M	6.6M